These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 35696582)

  • 1. Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia.
    Dong H; Ham JD; Hu G; Xie G; Vergara J; Liang Y; Ali A; Tarannum M; Donner H; Baginska J; Abdulhamid Y; Dinh K; Soiffer RJ; Ritz J; Glimcher LH; Chen J; Romee R
    Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2122379119. PubMed ID: 35696582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAR memory-like NK cells targeting the membrane proximal domain of mesothelin demonstrate promising activity in ovarian cancer.
    Tarannum M; Dinh K; Vergara J; Birch G; Abdulhamid YZ; Kaplan IE; Ay O; Maia A; Beaver O; Sheffer M; Shapiro R; Ali AK; Dong H; Ham JD; Bobilev E; James S; Cameron AB; Nguyen QD; Ganapathy S; Chayawatto C; Koreth J; Paweletz CP; Gokhale PC; Barbie DA; Matulonis UA; Soiffer RJ; Ritz J; Porter RL; Chen J; Romee R
    Sci Adv; 2024 Jul; 10(28):eadn0881. PubMed ID: 38996027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia.
    Sedloev D; Chen Q; Unglaub JM; Schanda N; Hao Y; Besiridou E; Neuber B; Schmitt A; Raffel S; Liu Y; Janssen M; Müller-Tidow C; Schmitt M; Sauer T
    J Hematol Oncol; 2024 Sep; 17(1):85. PubMed ID: 39285441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells.
    Ma Q; Garber HR; Lu S; He H; Tallis E; Ding X; Sergeeva A; Wood MS; Dotti G; Salvado B; Ruisaard K; Clise-Dwyer K; John LS; Rezvani K; Alatrash G; Shpall EJ; Molldrem JJ
    Cytotherapy; 2016 Aug; 18(8):985-994. PubMed ID: 27265873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities.
    Christodoulou I; Ho WJ; Marple A; Ravich JW; Tam A; Rahnama R; Fearnow A; Rietberg C; Yanik S; Solomou EE; Varadhan R; Koldobskiy MA; Bonifant CL
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34896980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAR-T cells targeting a nucleophosmin neoepitope exhibit potent specific activity in mouse models of acute myeloid leukaemia.
    Xie G; Ivica NA; Jia B; Li Y; Dong H; Liang Y; Brown D; Romee R; Chen J
    Nat Biomed Eng; 2021 May; 5(5):399-413. PubMed ID: 33046866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123.
    Morgan MA; Kloos A; Lenz D; Kattre N; Nowak J; Bentele M; Keisker M; Dahlke J; Zimmermann K; Sauer M; Heuser M; Schambach A
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hu8F4-CAR T cells with mutated Fc spacer segment improve target specificity and mediate anti-leukemia activity in vivo.
    He H; Vedia RA; Lu S; Li Q; Cox KR; St John L; Sergeeva A; Clise-Dwyer K; Alatrash G; Shpall EJ; Ma Q; Molldrem JJ
    Cytotherapy; 2024 Nov; 26(11):1331-1340. PubMed ID: 39033444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL.
    Ureña-Bailén G; Dobrowolski JM; Hou Y; Dirlam A; Roig-Merino A; Schleicher S; Atar D; Seitz C; Feucht J; Antony JS; Mohammadian Gol T; Handgretinger R; Mezger M
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.
    Romee R; Rosario M; Berrien-Elliott MM; Wagner JA; Jewell BA; Schappe T; Leong JW; Abdel-Latif S; Schneider SE; Willey S; Neal CC; Yu L; Oh ST; Lee YS; Mulder A; Claas F; Cooper MA; Fehniger TA
    Sci Transl Med; 2016 Sep; 8(357):357ra123. PubMed ID: 27655849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-Induced Memory-Like NK Cells: From the Basics to Clinical Applications.
    Terrén I; Orrantia A; Astarloa-Pando G; Amarilla-Irusta A; Zenarruzabeitia O; Borrego F
    Front Immunol; 2022; 13():884648. PubMed ID: 35603208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells.
    Uppendahl LD; Felices M; Bendzick L; Ryan C; Kodal B; Hinderlie P; Boylan KLM; Skubitz APN; Miller JS; Geller MA
    Gynecol Oncol; 2019 Apr; 153(1):149-157. PubMed ID: 30658847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells.
    Bexte T; Albinger N; Al Ajami A; Wendel P; Buchinger L; Gessner A; Alzubi J; Särchen V; Vogler M; Rasheed HM; Jung BA; Wolf S; Bhayadia R; Oellerich T; Klusmann JH; Penack O; Möker N; Cathomen T; Rieger MA; Imkeller K; Ullrich E
    Nat Commun; 2024 Sep; 15(1):8439. PubMed ID: 39349459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer-Based "Off-the-Shelf" Acute Myeloid Leukemia Immunotherapies.
    Kloess S; Oberschmidt O; Dahlke J; Vu XK; Neudoerfl C; Kloos A; Gardlowski T; Matthies N; Heuser M; Meyer J; Sauer M; Falk C; Koehl U; Schambach A; Morgan MA
    Hum Gene Ther; 2019 Apr; 30(4):381-401. PubMed ID: 30734584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia.
    Limongello R; Marra A; Mancusi A; Bonato S; Hoxha E; Ruggeri L; Hui S; Velardi A; Pierini A
    Front Immunol; 2021; 12():695051. PubMed ID: 34413848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia.
    Forghieri F; Riva G; Lagreca I; Barozzi P; Bettelli F; Paolini A; Nasillo V; Lusenti B; Pioli V; Giusti D; Gilioli A; Colasante C; Galassi L; Catellani H; Donatelli F; Talami A; Maffei R; Martinelli S; Potenza L; Marasca R; Tagliafico E; Manfredini R; Trenti T; Comoli P; Luppi M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas.
    Gang M; Marin ND; Wong P; Neal CC; Marsala L; Foster M; Schappe T; Meng W; Tran J; Schaettler M; Davila M; Gao F; Cashen AF; Bartlett NL; Mehta-Shah N; Kahl BS; Kim MY; Cooper ML; DiPersio JF; Berrien-Elliott MM; Fehniger TA
    Blood; 2020 Nov; 136(20):2308-2318. PubMed ID: 32614951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of the TIGIT-CD155/CD112 axis enhances functionality of NK-92 but not cytokine-induced memory-like NK cells toward CD155-expressing acute myeloid leukemia.
    Seel K; Schirrmann RL; Stowitschek D; Ioseliani T; Roiter L; Knierim A; André MC
    Cancer Immunol Immunother; 2024 Jul; 73(9):180. PubMed ID: 38967649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine-Induced Memory-Like NK Cells: Emerging strategy for AML immunotherapy.
    Bakhtiyaridovvombaygi M; Yazdanparast S; Mikanik F; Izadpanah A; Parkhideh S; Shahbaz Ghasabeh A; Roshandel E; Hajifathali A; Gharehbaghian A
    Biomed Pharmacother; 2023 Dec; 168():115718. PubMed ID: 37857247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semaphorin 7A modulates cytokine-induced memory-like responses by human natural killer cells.
    Ghofrani J; Lucar O; Dugan H; Reeves RK; Jost S
    Eur J Immunol; 2019 Aug; 49(8):1153-1166. PubMed ID: 31016720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.